Anti-FA2H monoclonal antibody

Pre-made anti-FA2H monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FA2H/FA2H products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0786-Ab-1/ GM-Tg-hg-IP0786-Ab-2Anti-Human FA2H monoclonal antibodyHuman
GM-Tg-rg-IP0786-Ab-1/ GM-Tg-rg-IP0786-Ab-2Anti-Rat FA2H monoclonal antibodyRat
GM-Tg-mg-IP0786-Ab-1/ GM-Tg-mg-IP0786-Ab-2Anti-Mouse FA2H monoclonal antibodyMouse
GM-Tg-cynog-IP0786-Ab-1/ GM-Tg-cynog-IP0786-Ab-2Anti-Cynomolgus/ Rhesus macaque FA2H monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0786-Ab-1/ GM-Tg-felg-IP0786-Ab-2Anti-Feline FA2H monoclonal antibodyFeline
GM-Tg-cang-IP0786-Ab-1/ GM-Tg-cang-IP0786-Ab-2Anti-Canine FA2H monoclonal antibodyCanine
GM-Tg-bovg-IP0786-Ab-1/ GM-Tg-bovg-IP0786-Ab-2Anti-Bovine FA2H monoclonal antibodyBovine
GM-Tg-equg-IP0786-Ab-1/ GM-Tg-equg-IP0786-Ab-2Anti-Equine FA2H monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0786-Ab-1/ GM-Tg-hg-IP0786-Ab-2; GM-Tg-rg-IP0786-Ab-1/ GM-Tg-rg-IP0786-Ab-2;
GM-Tg-mg-IP0786-Ab-1/ GM-Tg-mg-IP0786-Ab-2; GM-Tg-cynog-IP0786-Ab-1/ GM-Tg-cynog-IP0786-Ab-2;
GM-Tg-felg-IP0786-Ab-1/ GM-Tg-felg-IP0786-Ab-2; GM-Tg-cang-IP0786-Ab-1/ GM-Tg-cang-IP0786-Ab-2;
GM-Tg-bovg-IP0786-Ab-1/ GM-Tg-bovg-IP0786-Ab-2; GM-Tg-equg-IP0786-Ab-1/ GM-Tg-equg-IP0786-Ab-2
Products NameAnti-FA2H monoclonal antibody
Formatmab
Target NameFA2H
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FA2H monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0786-Ag-1Recombinant multi-species FA2H/ FAAH/ FAH1 protein


    Target information

    Target IDGM-IP0786
    Target NameFA2H
    Gene ID79152,338521,307855,710403,610417,101089563,516891,100068800
    Gene Symbol and SynonymsFA2H,FAAH,FAH1,FAXDC1,G630055L08Rik,RGD1310347,SCS7,SPG35,Wdr59
    Uniprot AccessionQ7L5A8,Q2LAM0
    Uniprot Entry NameFA2H_HUMAN,FA2H_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000103089
    Target ClassificationN/A

    The target: FA2H, gene name: FA2H, also named as FAAH, FAH1, FAXDC1, SCS7, SPG35. This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.